IRLAB Therapeutics AB
STO:IRLAB A

Watchlist Manager
IRLAB Therapeutics AB Logo
IRLAB Therapeutics AB
STO:IRLAB A
Watchlist
Price: 3.6 SEK -0.55% Market Closed
Market Cap: 341.6m SEK

Wall Street
Price Targets

IRLAB A Price Targets Summary
IRLAB Therapeutics AB

There are no price targets for IRLAB A.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
IRLAB Therapeutics AB Competitors:
Price Targets
EMCURE
Emcure Pharmaceuticals Ltd
18% Upside
005500
Samjin Pharmaceutical Co Ltd
20% Upside
JUBLPHARMA
Jubilant Pharmova Ltd
16% Upside
GSK
GlaxoSmithKline PLC
17% Upside
VY4
SNDL Inc
165% Upside
KILITCH
Kilitch Drugs (India) Ltd
16% Downside
AARTIDRUGS
Aarti Drugs Ltd
0% Downside
AXSM
Axsome Therapeutics Inc
65% Upside

Revenue
Forecast

Revenue Estimate
IRLAB Therapeutics AB

For the last 8 years the compound annual growth rate for IRLAB Therapeutics AB's revenue is 125%. The projected CAGR for the next 2 years is -25%.

125%
Past Growth
-25%
Estimated Growth
Estimates Accuracy
-15%
Average Miss

Operating Income
Forecast

Operating Income Estimate
IRLAB Therapeutics AB

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Net Income
Forecast

Net Income Estimate
IRLAB Therapeutics AB

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-56%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is IRLAB A's stock price target?
Not Available

IRLAB A doesn't have any price targets made by Wall Street professionals.

What is IRLAB Therapeutics AB's Revenue forecast?
Projected CAGR
-25%

For the last 8 years the compound annual growth rate for IRLAB Therapeutics AB's revenue is 125%. The projected CAGR for the next 2 years is -25%.

Back to Top